title: Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cells.
abstract: The functional contributions of the alpha and gamma subunit domains of the high affinity receptor for IgE (Fcepsilon-RI) were determined following chimeric receptor aggregation. Chimeric receptors of the extracellular (EC) and cytoplasmic tail (CT) domains of FcepsilonRI and the IL-2R p55 subunit (I) were constructed and stably expressed in RBL-2H3 cells. Signaling (inositol phosphate production, tyrosine phosphorylation, Ca2+ mobilization, and secretion of histamine and arachidonic acid metabolites) via alpha/gamma/gamma or I/gamma/gamma was similar to the native rat receptor, and both were shown to associate with endogenous FcepsilonRIbeta and FcepsilonRIgamma subunits. Therefore, the contributions of the EC domains could not be evaluated. The chimeras alpha/I/gamma and I/I/gamma were found to be single polypeptide chains, as they did not associate with beta and gamma. Signaling via alpha/I/gamma resulted in the appearance of biochemical events common to the native receptor. Cross-linking I/I/gamma elicited histamine release, [14C]arachidonic acid metabolites, tyrosine phosphorylation, Ca2+ mobilization, and only inositol trisphosphate production, which were not of a similar magnitude to the native FcepsilonRI. No biochemical events were elicited by cross-linking alpha/I/I or I/I/I. These results demonstrate that both the FcepsilonRIalpha EC domain and the FcepsilonRIgamma CT domain are essential for the FcepsilonRI signaling process, and that while FcepsilonRIIgamma CT plays a critical role in FepsilonRI signaling, the EC domain of FcepsilonRIalpha has a major contribution in signaling, as well as a role in modulating the magnitude of the biochemical events.
authors.affiliation: Department of Inflammation and Autoimmune Disease, Hoffmann-La Roche, Nutley, NJ 07110, USA.
authors.forename: B
authors.initials: B
authors.lastname: Repetto
authors.forename: G
authors.initials: G
authors.lastname: Bandara
authors.forename: H
authors.initials: H
authors.lastname: Kado-Fong
authors.forename: J D
authors.initials: JD
authors.lastname: Larigan
authors.forename: G A
authors.initials: GA
authors.lastname: Wiggan
authors.forename: D
authors.initials: D
authors.lastname: Pocius
authors.forename: M
authors.initials: M
authors.lastname: Basu
authors.forename: A M
authors.initials: AM
authors.lastname: Gilfillan
authors.forename: J P
authors.initials: JP
authors.lastname: Kochan
mesh_terms: D000818:Animals; D002118:Calcium / Q000378:metabolism; D004789:Enzyme Activation; D006636:Histamine Release; D006801:Humans; D007295:Inositol Phosphates / Q000378:metabolism; D008407:Mast Cells / Q000502:physiology*; D011485:Protein Binding; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D051381:Rats; D017455:Receptors, IgE / Q000737:chemistry* / Q000502:physiology; D015375:Receptors, Interleukin-2 / Q000737:chemistry; D011993:Recombinant Fusion Proteins; D015398:Signal Transduction; D013329:Structure-Activity Relationship
chemical_list: D007295:Inositol Phosphates; D017455:Receptors, IgE; D015375:Receptors, Interleukin-2; D011993:Recombinant Fusion Proteins; D011505:Protein-Tyrosine Kinases; D002118:Calcium